Global Summit and Award Ceremonies
for Cancer Research & Entrepreneurship

Upcoming: Saturday, October 22, 2022


Co-Hosted by 

The Asian Fund for Cancer Research, National Foundation for Cancer Research, and AIM-HI Accelerator Fund will co-host a trio of programs celebrating cancer research success and the impact of oncology innovation. Featured Programs include New Frontiers in Cancer Research, Women’s Leadership Luncheon, and Szent-Györgyi Prize Award Ceremony.

The event will be held live in Washington, DC, USA, and also streamed online for those unable to attend in person. Attendees will include cancer research donors, cancer patients, academic and industry professionals, and other public members interested in learning about cancer research discoveries and the powerful disease-fighting products and tools.

We hope you will join us!

Why Should You Attend This Event?

  • Be inspired by world-renowned speakers on the latest landscape change of translational cancer research
  • Actively engage in thought-provoking discussions with key opinion leaders
  • Personally interact with award-winning pioneer scientists and join the celebration of their breakthrough cancer discoveries

Program Agenda

Part I: New Frontiers for Cancer Research

8:45 am -12:25 pm

8:45-8:55 am:

Opening and Welcome Remarks

Sujuan Ba, Ph.D., CEO of NFCR, Co-Founder of AIM-HI, & Founder of AFCR

Session I: Molecular approaches to understand and treat cancer

8:45-10:30 am:

Moderator: Web Cavenee, Ph.D., Chair of NFCR Scientific Advisory Board; Distinguished Professor of Medicine, University of California, San Diego and Director of Strategic Alliances, Ludwig Institute for Cancer Research

Panel Members:

  • Ken C. Anderson, M.D., Dana-Farber Cancer Institute, Professor of Medicine, Harvard; Physician Oncology, Brigham and Women’s Hospital
  • Teresa Davoli, Ph.D., Assistant Professor, Cancer Genetics and Genomics, New York University
  • Aaron N. Hata, M.D., Ph.D., Assistant Professor of Medicine, Harvard 
  • Isidore Rigoutsos, Ph.D., Professor in Computational Medicine, Thomas Jefferson University
  • Suzanne Topalian, M.D., Professor of Oncology and Surgery, Johns Hopkins University
  • Katherine Uyhazi, M.D., Ph.D., Assistant Professor of Ophthalmology, University of Pennsylvania 

10:30-10:45 am Coffee Break

Session II: New Approaches to Treat Breast, Pancreatic and Head and Neck Cancer

10:45am-12:20 pm:

Moderator: Jennifer Grandis, M.D., American Cancer Society Professor of Otolaryngology, University of California, San Francisco


Panel Members: 

  • Lisa Coussens, Ph.D., Professor and Chair, Department of Cell, Developmental & Cancer Biology, Oregon Health and Sciences University
  • Daniel A. Haber, M.D., Ph.D., Director, Massachusetts General Hospital Cancer Center
  • Courtney Houchen, M.D., Professor, Chief of Digestive Diseases and Nutrition, Oklahoma University School of Medicine
  • Daniel E. Johnson, Ph.D., Professor and Vice Chair of Research, Otolaryngology and Head and Neck Surgery, University of California, San Francisco
  • Kornelia Polyak, M.D., Ph.D., Professor of Medicine, Dana-Farber Cancer Institute, Harvard 
  • Xiang-Lei Yang, Ph.D., Professor of Molecular Biology and Medicine, Scripps Research

12:20-12:25 pm:

Closing Remarks: 

Alfred Slanetz, Ph.D. Chairman of Board of Directors, NFCR; CEO of Geneius Biotechnology

Part II:Luncheon Award Ceremony for Entrepreneurship & Women’s Leadership

12:30-2:00 pm

12:30-2:00 pm:

Emcee: Rose Wang, MBA, Executive Advisor of AIM-HI Accelerator Fund

Introduction of the AIM-HI Leadership & Entrepreneurship program

Sujuan Ba, Ph.D., CEO of NFCR, Co-Founder of AIM-HI, & Founder of AFCR

Award Presentation of the AIM-HI Beacon Award for Women Leaders in Oncology

  • Overview of the Beacon Award Selection Process: Web Cavenee, Ph.D., Co-Chair of the Selection Committee of the Beacon Award
  • Introduction of the Awardee by the Nominator, Raju Kucherlapati, Ph.D., Paul C. Cabot Professor of Genetics and Professor of Medicine, Harvard Medical School
  • Presenting the Beacon Award Medallion to the Recipient by the Award Selection Committee Members
  • 2022 Beacon Award Winner Award Speech: Anna Barker, Ph.D., Chief Strategy Officer of Ellison Institute for Transformative Medicine 

Award Presentation of the Top Finalists for the 2022 Women’s Venture Competition & 2022 BRACE Award Venture Competition: Pamela Garzone, Ph.D., Co-Chair of the Competition Selection & Judging Committees; Chief Development Officer of Anixa Biosciences 

Women’s Venture Competition: Dimitra Georganopoulou, Ph.D., Co-Chair of the Competition Investment Committee; General Partner of Qral Ventures

  • Johanna Webb, President of RiverWalk Therapeutics
  • Revital Mandil-Levin, Ph.D., CEO & Co-Founder of Nanocarry Therapeutics
  • Rosa Hwang, M.D., Co-Founder of Stellanova Therapeutics

BRACE Award Venture Competition: Beverly Lu, Ph.D., Co-Chair of the Competition Investment Committee; Investment Manager, Health of Emerson Collective

  • Li Chai, M.D., Co-Founder of Believer Pharmaceuticals
  • Rajiv Datar, Ph.D., Co-Founder & CEO of Propelle Therapeutics

Closing Remarks: Rose Wang

2:00-2:15 pm Coffee Break

Part III: AIM-HI Portfolio Companies Showcase

2:15-4:00 pm

2:15-4:00 pm:

Welcome and Opening Remarks: 

Sujuan Ba, Ph.D., CEO of NFCR, Co-Founder of AIM-HI, & Founder of AFCR


  • Lora Green, Ph.D., J.D., Partner, Patents & Innovations, Wilson Sonsini Goodrich & Rosati: 
  • Critical Intellectual Property Protection Strategies & Common Pitfalls for Early-stage Companies

Panel Discussion: Opportunities & Challenges Facing Leadership of Early-stage Oncology Companies

Moderator: Raju Kucherlapati, Ph.D., Paul C. Cabot Professor of Genetics and Professor of Medicine, Harvard Medical School

Panel Members:

  • Pritesh Gandhi, PharmD, CEO of TellBio
  • Vlad Hogenhuis, M.D., MBA, CEO of Chimera Bioengineering
  • John Luk, DMedSc, EMBA, CEO of Arbele Bio
  • Ken Malone, Ph.D., CEO of Rasio Therapeutics
  • María Varela, CEO of Ardan Pharma

Closing Remarks: 

Charlie Weatherspoon, Chair of the Board of the Director, AIM-HI Accelerator Fund

4:00-6:00 pm Intermission

Part IV: 2022 Szent-Györgyi Prize Dinner & Award Ceremony – Black-Tie Optional

6:00-7:00 pm Cocktail Reception / 7:00-8:30 pm Dinner & Award Ceremony

6:00-7:00 pm:

Cocktail Reception

7:00-8:30 pm:

Dinner & Award Ceremony

Moment of Silence

Opening and Welcome Remarks: Sujuan Ba, Ph.D., CEO of NFCR, Co-Founder of AIM-HI, & Founder of AFCR; Co-Chair of the 2022 Selection Committee for the Szent-Györgyi Prize

Introduction of the 2022 Szent-Györgyi Prize Winner:

Doug Lowy, M.D., 2018 Szent-Györgyi Prize Winner; Principal Deputy Director of the U.S. National Cancer Institute 

Award Trophy Presentation

Dr. Sujuan Ba, Co-Chair of the 2022 Selection Committee for the Szent-Györgyi Prize

2022 Szent-Györgyi Prize Winner Award Speech

Rakesh K. Jain, Ph.D., Andrew Werk Cook Professor of Radiation Oncology, Harvard Medical School; Director, Edwin L. Steele Laboratories for Tumor Biology, Massachusetts General Hospital

Introduction of Lance Kawaguchi, Board Member of NFCR & Chair of AFCR; CEO of Cure Brain Cancer Foundation: Sujuan Ba, Ph.D.

Introduction of Cancer Research Advocates: Lance Kawaguchi

Chelsea Hu, BASIS Independent, McLean

Greyson and Katie Banovich: Phoenix, AZ

Acknowledgments & Closing Remarks: Lance Kawaguchi

Sponsorship Opportunities

Inquiries regarding event sponsorship can be made by e-mail at